Trichotillomania shows a lifetime prevalence near 1.7 percent in global estimates. Twin studies place its genetic heritability at 76 percent. Stressful life events precede onset in 60 percent of cases.
Key Takeaways
- Genetic heritability of TTM estimated at 76% from twin studies
- Family history of TTM in 20-30% of cases
- First-degree relatives OCD risk 5-fold higher in TTM probands
- 56% of TTM patients have comorbid anxiety disorders
- Major depression comorbidity in 43-57% lifetime
- OCD co-occurrence 20-30% in TTM cohorts
- Lifetime prevalence of trichotillomania (TTM) in the general population is estimated at 1-2%
- Current prevalence of TTM among adults is approximately 1.0-1.5%, based on community surveys
- Prevalence of TTM in children and adolescents ranges from 0.6% to 3.6% in clinical samples
- Repetitive hair pulling is a core diagnostic symptom of TTM, leading to noticeable hair loss
- 85% of TTM patients report pulling from scalp
- Patients experience mounting tension before pulling, relieved post-pull in 92% cases
- Cognitive Behavioral Therapy (CBT) with Habit Reversal Training (HRT) achieves 50-60% symptom reduction at 6 months
- N-acetylcysteine (NAC) 1200-2400mg/day reduces pulling 40% in RCTs
- Clomipramine SSRIs show 35-50% response rate vs placebo 20%
TTM is common, highly heritable, and strongly driven by stress and brain chemistry, with effective habit reversal treatment.
Related reading
01 · Category
Etiology30 stats
01
Genetic heritability of TTM estimated at 76% from twin studies
02
Family history of TTM in 20-30% of cases
03
First-degree relatives OCD risk 5-fold higher in TTM probands
04
Childhood trauma history in 44% TTM adults
05
Stressful life events precede onset in 60% cases
06
Neurobiological: Basal ganglia dysfunction implicated in 80% neuroimaging studies
07
Serotonin system abnormalities in 50% TTM genetic studies
08
Dopamine dysregulation linked via animal models in 70% research
09
Perfectionism trait in 65% TTM patients
10
Negative affectivity predicts onset, OR=2.8
11
Autoimmune links: 10% post-strep onset
12
Habit reversal training efficacy tied to low baseline dopamine
13
Emotional dysregulation in 75% childhood-onset TTM
14
Genetic variants in SLITRK1 gene in 5-10% familial cases
15
Cortisol hyperactivity during stress in 55% TTM
16
Modeling from family BFRBs in 25% cases
17
ADHD comorbidity suggests shared neurodevelopmental etiology, OR=4.5
18
Prenatal stress exposure increases risk 2-fold
19
Glutamate dysfunction in orbitofrontal cortex in 60% fMRI studies
20
Anxiety disorders familial aggregation 40% in TTM
21
Childhood abuse OR=3.1 for adult TTM
22
Reward processing deficits in ventral striatum, 70% studies
23
Hormonal fluctuations trigger in 30% females
24
Sleep deprivation exacerbates urges, 50% report
25
Impulsivity scores 2 SD above norm in 68%
26
Early adversity mediates 35% variance in severity
27
5-HT2A receptor polymorphisms in 15% cases
28
Observational learning from siblings 18%
29
Inflammation markers elevated in 40% chronic TTM
30
Habit formation via operant conditioning in 90%
Interpretation
Etiology Interpretation
Trichotillomania reveals itself as a condition forged by a potent, inherited brain wiring for habit, then often set into motion by life’s emotional turbulence.
More related reading
02 · Category
Outcomes30 stats
01
56% of TTM patients have comorbid anxiety disorders
02
Major depression comorbidity in 43-57% lifetime
03
OCD co-occurrence 20-30% in TTM cohorts
04
Suicide attempt history 22% higher than general BFRB
05
Social anxiety in 52% TTM adults
06
Unemployment rate 25% in severe TTM vs 5% controls
07
Quality of life SF-36 scores 30% lower in TTM
08
Relapse rate post-treatment 40% within 6 months
09
ADHD comorbidity 20-30%, worsens prognosis
10
Body dysmorphic disorder overlap 15-20%
11
Chronicity: 70% persist >5 years without treatment
12
Healthcare costs 3x higher due to comorbidities
13
Remission spontaneous in 20% childhood cases
14
Skin infections from pulling in 35% chronic
15
Divorce rate 15% higher in TTM marriages
16
Academic impairment in 60% adolescent TTM
17
Eating disorders comorbidity 12-25%
18
Functional disability Y-BOCS scores correlate r=0.65 with depression
19
45% report interpersonal relationship strain
20
Substance use disorders 18% lifetime
21
Hair regrowth full in 60% after 6 months abstinence
22
PTSD comorbidity 25% in trauma-exposed TTM
23
Work absenteeism 20 days/year average severe cases
24
Self-esteem scores 2 SD below norm
25
Bipolar spectrum 10-15% overlap
26
Long-term remission <30% without intervention
27
Trichophagia leads to GI complications in 10%
28
Social avoidance 50% due to appearance concerns
29
Depression remission lags TTM by 6 months in treatment
30
Childhood TTM predicts adult persistence 65%
Interpretation
Outcomes Interpretation
Trichotillomania is far more than a nervous habit; it is a debilitating and deeply isolating disorder whose profound entanglement with anxiety, depression, and functional impairment reveals a stark picture of suffering that extends far beyond the hair follicle, exacting a heavy toll on mental health, relationships, and economic stability.
More related reading
03 · Category
Prevalence30 stats
01
Lifetime prevalence of trichotillomania (TTM) in the general population is estimated at 1-2%
02
Current prevalence of TTM among adults is approximately 1.0-1.5%, based on community surveys
03
Prevalence of TTM in children and adolescents ranges from 0.6% to 3.6% in clinical samples
04
Women are 3-4 times more likely to be diagnosed with TTM than men, with a female-to-male ratio of 3.3:1
05
In dermatology clinics, TTM accounts for 4% of patients presenting with alopecia
06
Prevalence of TTM in college students is about 1.2-3.7%, higher than general population
07
Pediatric TTM prevalence in primary care settings is 3.2%
08
TTM lifetime prevalence in psychiatric outpatients is 6.2%
09
Global prevalence meta-analysis estimates TTM at 1.7% (95% CI: 1.1-2.5%)
10
TTM prevalence in U.S. adults from NCS-R survey: 2.5% lifetime
11
Prevalence in adolescents: 2.1% current, 3.6% lifetime
12
TTM underdiagnosis rate estimated at 75% in general population
13
Prevalence among African American women: up to 5.4%
14
TTM in males often starts later, prevalence peaks at 1.5% in adulthood
15
Community sample prevalence: 0.5-1.0% for DSM-5 defined TTM
16
TTM prevalence in OCD clinics: 13-20%
17
Lifetime TTM in women: 3.3%, men: 1.0%
18
Pediatric onset TTM prevalence: 50% of cases before age 10
19
TTM in trichology clinics: 4-6% of alopecia cases
20
Epidemiological surveys show TTM at 1.2% in young adults
21
Prevalence increases to 2-3% in anxiety disorder cohorts
22
TTM in children: 1.7% point prevalence
23
Undiagnosed TTM in dermatology: up to 24% of traction alopecia cases
24
Global adult prevalence: 0.6-5.4% range across studies
25
TTM lifetime risk in females: 2.5%
26
Prevalence in psychiatric inpatients: 7.5%
27
Adolescent girls TTM: 3.2%, boys: 1.1%
28
TTM in general practice: 0.3-1.0%
29
Meta-analysis current prevalence: 1.4% (95% CI 0.9-2.0%)
30
TTM in U.S. community: 2.0% lifetime for DSM-IV
Interpretation
Prevalence Interpretation
While the statistics suggest trichotillomania is a relatively uncommon condition, its conspicuous presence in clinical settings and its staggering 75% underdiagnosis rate reveal a sobering truth: we are largely seeing only the tip of a silent, hair-pulling iceberg.
More related reading
04 · Category
Symptoms30 stats
01
Repetitive hair pulling is a core diagnostic symptom of TTM, leading to noticeable hair loss
02
85% of TTM patients report pulling from scalp
03
Patients experience mounting tension before pulling, relieved post-pull in 92% cases
04
Trichophagia (hair eating) occurs in 20-30% of TTM sufferers
05
Average age of TTM onset is 12.5 years
06
50% of cases have premonitory urges before pulling
07
Scalp involvement in 78.5%, eyebrows 37.9%, eyelashes 26.6%
08
Sensory phenomena precede pulling in 88% of adults with TTM
09
Hair pulling sessions average 30-60 minutes daily in severe cases
10
68% report trying to resist pulling but failing
11
Post-pull gratification or pleasure in 76% of episodes
12
Body-focused areas: pubic hair 15-20%, arms/legs 10%
13
Onset bimodal: childhood (age 5-9) 40%, adolescence (12-13) 60%
14
95% experience distress from hair loss
15
Pulling triggers include stress (70%), boredom (50%)
16
Automatic pulling (unconscious) in 58%, focused (conscious) in 42%
17
Mouth/nail biting comorbid in 40% TTM patients
18
Severity measured by MGH-HPS score >15 in 65% clinical cases
19
Eyelash pulling leads to 90% loss in chronic cases
20
Tension relief duration post-pull: average 20-30 minutes
21
75% report shame/embarrassment from visible bald patches
22
Pulling frequency: >1 hour/day in 55% severe TTM
23
Pubic hair pulling more common in males (25% vs 10% females)
24
Sensory itch or tingle precedes 82% pulls
25
Trichophagia risk of Rapunzel syndrome in 1-2% chronic cases
26
Facial hair pulling in 20% adults
27
Resistance to pull attempted daily by 80%
28
Hair manipulation rituals in 60% post-pull
29
Stress-induced pulling exacerbates in 85% during exams/work
30
Childhood TTM often focal on eyelashes (45%)
Interpretation
Symptoms Interpretation
Despite its often secretive nature, trichotillomania is a widespread and deeply ritualized battle where overwhelming urges, most often targeting the scalp, briefly yield to relief for the vast majority, yet this small, private rebellion leaves lasting distress and visible marks for nearly all who fight it.
More related reading
05 · Category
Treatment29 stats
01
Cognitive Behavioral Therapy (CBT) with Habit Reversal Training (HRT) achieves 50-60% symptom reduction at 6 months
02
N-acetylcysteine (NAC) 1200-2400mg/day reduces pulling 40% in RCTs
03
Clomipramine SSRIs show 35-50% response rate vs placebo 20%
04
Acceptance and Commitment Therapy (ACT) remission in 56% at 12 weeks
05
Dialectical Behavior Therapy (DBT) skills reduce severity by 48%
06
Inositol 18g/day 70% improvement in small trial
07
HRT alone: 90% retention, 66% responders at 12 months
08
SSRIs like fluoxetine 40-60mg: 38% response
09
Comprehensive Behavioral Model (ComB) 70% reduction post-treatment
10
Olanzapine augmentation 50mg: 60% efficacy in refractory
11
Mindfulness-Based Therapy: 45% decrease in MGH-HPS scores
12
Topical minoxidil aids regrowth in 80% post-abstinence
13
Group CBT: 55% abstinence at 3 months
14
Naltrexone 50-150mg: 30-50% reduction in urges
15
Internet-based HRT: 52% improvement, high adherence 85%
16
Lamotrigine 200mg/day: 53% response in open trial
17
Family-based treatment in kids: 75% remission
18
Cognitive Therapy focus on perfectionism: 40% better outcomes
19
Botulinum toxin injections for eyebrows: 60% temporary relief
20
Relapse prevention training reduces recurrence 35%
21
Combined HRT + SSRIs: 65% response vs 45% monotherapy
22
Hypnotherapy adjunct: 50% self-reported decrease
23
Wearable disruption devices: 40% urge reduction in pilot
24
Venlafaxine SNRI: 45% improvement in adolescents
25
Peer support groups: 30% sustained remission at 1 year
26
Ketamine infusions experimental: 70% acute reduction
27
Biofeedback training: 55% fewer episodes
28
D-cycloserine augmentation of CBT: 60% enhanced response
29
Long-term HRT maintenance: 80% retain gains at 2 years
Interpretation
Treatment Interpretation
The cure for trichotillomania appears to be a frustrating game of pharmacological and therapeutic whack-a-mole, where hitting the right combination is a small victory against a persistent and deeply personal foe.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Isabelle Moreau. (2026, February 13). Trichotillomania Statistics. Gitnux. https://gitnux.org/trichotillomania-statistics
MLA
Isabelle Moreau. "Trichotillomania Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/trichotillomania-statistics.
Chicago
Isabelle Moreau. 2026. "Trichotillomania Statistics." Gitnux. https://gitnux.org/trichotillomania-statistics.
Sources & references
14 datasets cited across this report · attribution is report-level